Literature DB >> 7600291

Oct-2 is required early in T cell-independent B cell activation for G1 progression and for proliferation.

L M Corcoran1, M Karvelas.   

Abstract

Oct-2, a POU homeodomain protein expressed primarily in B cells, is a powerful transcriptional activator that binds to DNA at sites appropriately placed for major effects on immunoglobulin gene expression. Our examination of B cell development and function in Oct-2 null mice did not support an essential role for Oct-2 early in B cell development. Rather, Oct-2 was required later, when B cells were induced to differentiate to antibody-secreting cells. We show here that Oct-2 is not required for normal immunoglobulin production by mature B lymphocytes. Instead, it is essential for a normal proliferative response to polyclonal mitogens. Responses to signals from activated T cells are unaffected. The requirement for Oct-2 maps to an early activation step in G1, during which B cells make the commitment to progress through the cell cycle and to divide.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7600291     DOI: 10.1016/1074-7613(94)90035-3

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  28 in total

1.  B cell development and immunoglobulin transcription in Oct-1-deficient mice.

Authors:  Victoria E H Wang; Dean Tantin; Jianzhu Chen; Phillip A Sharp
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-04       Impact factor: 11.205

2.  Normal B-1a cell development requires B cell-intrinsic NFATc1 activity.

Authors:  Robert Berland; Henry H Wortis
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-31       Impact factor: 11.205

3.  Gene structure and characterization of the murine homologue of the B cell-specific transcriptional coactivator OBF-1.

Authors:  D B Schubart; P Sauter; S Massa; E M Friedl; H Schwarzenbach; P Matthias
Journal:  Nucleic Acids Res       Date:  1996-05-15       Impact factor: 16.971

4.  Oct-1 [corrected] and Oct-2 DNA-binding site specificity is regulated in vitro by different kinases.

Authors:  S J Grenfell; D S Latchman; N S Thomas
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

5.  Coactivation by OCA-B: definition of critical regions and synergism with general cofactors.

Authors:  Y Luo; H Ge; S Stevens; H Xiao; R G Roeder
Journal:  Mol Cell Biol       Date:  1998-07       Impact factor: 4.272

6.  Flanking sequences modulate the cell specificity of M-CAT elements.

Authors:  S B Larkin; I K Farrance; C P Ordahl
Journal:  Mol Cell Biol       Date:  1996-07       Impact factor: 4.272

7.  Using altered specificity Oct-1 and Oct-2 mutants to analyze the regulation of immunoglobulin gene transcription.

Authors:  P C Shah; E Bertolino; H Singh
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

8.  Defective B cell receptor-mediated responses in mice lacking the Ets protein, Spi-B.

Authors:  G H Su; H M Chen; N Muthusamy; L A Garrett-Sinha; D Baunoch; D G Tenen; M C Simon
Journal:  EMBO J       Date:  1997-12-01       Impact factor: 11.598

Review 9.  POU domain transcription factors in embryonic development.

Authors:  G J Veenstra; P C van der Vliet; O H Destrée
Journal:  Mol Biol Rep       Date:  1997-08       Impact factor: 2.316

10.  OCA-B integrates B cell antigen receptor-, CD40L- and IL 4-mediated signals for the germinal center pathway of B cell development.

Authors:  X F Qin; A Reichlin; Y Luo; R G Roeder; M C Nussenzweig
Journal:  EMBO J       Date:  1998-09-01       Impact factor: 11.598

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.